Literature DB >> 22354752

The spleen contributes to stroke induced neurodegeneration through interferon gamma signaling.

Hilary A Seifert1, Christopher C Leonardo, Aaron A Hall, Derrick D Rowe, Lisa A Collier, Stanley A Benkovic, Alison E Willing, Keith R Pennypacker.   

Abstract

Delayed neuronal death associated with stroke has been increasingly linked to the immune response to the injury. Splenectomy prior to middle cerebral artery occlusion (MCAO) is neuroprotective and significantly reduces neuroinflammation. The present study investigated whether splenic signaling occurs through interferon gamma (IFNγ). IFNγ was elevated early in spleens but later in the brains of rats following MCAO. Splenectomy decreased the amount of IFNγ in the infarct post-MCAO. Systemic administration of recombinant IFNγ abolished the protective effects of splenectomy with a concurrent increase in INFγ expression in the brain. These results suggest a role for spleen-derived IFNγ in stroke pathology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22354752      PMCID: PMC4739736          DOI: 10.1007/s11011-012-9283-0

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  37 in total

1.  Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke.

Authors:  Arthur Liesz; Wei Zhou; Éva Mracskó; Simone Karcher; Henrike Bauer; Sönke Schwarting; Li Sun; Dunja Bruder; Sabine Stegemann; Adelheid Cerwenka; Clemens Sommer; Alexander H Dalpke; Roland Veltkamp
Journal:  Brain       Date:  2011-03       Impact factor: 13.501

2.  IL-17 and IFN-gamma mRNA expression is increased in the brain and systemically after permanent middle cerebral artery occlusion in the rat.

Authors:  H L Li; N Kostulas; Y M Huang; B G Xiao; P van der Meide; V Kostulas; V Giedraitas; H Link
Journal:  J Neuroimmunol       Date:  2001-05-01       Impact factor: 3.478

3.  Splenectomy-reduced hepatic injury induced by ischemia/reperfusion in the rat.

Authors:  Y Okuaki; H Miyazaki; M Zeniya; T Ishikawa; Y Ohkawa; S Tsuno; M Sakaguchi; M Hara; H Takahashi; G Toda
Journal:  Liver       Date:  1996-06

4.  Cord blood administration induces oligodendrocyte survival through alterations in gene expression.

Authors:  D D Rowe; C C Leonardo; A A Hall; M D Shahaduzzaman; L A Collier; A E Willing; K R Pennypacker
Journal:  Brain Res       Date:  2010-09-29       Impact factor: 3.252

5.  CD4+FoxP3+ regulatory T-cells in cerebral ischemic stroke.

Authors:  Xuefang Ren; Kozaburo Akiyoshi; Arthur A Vandenbark; Patricia D Hurn; Halina Offner
Journal:  Metab Brain Dis       Date:  2010-11-17       Impact factor: 3.584

6.  Timing of cord blood treatment after experimental stroke determines therapeutic efficacy.

Authors:  Jennifer D Newcomb; Craig T Ajmo; Cyndy D Sanberg; Paul R Sanberg; Keith R Pennypacker; Alison E Willing
Journal:  Cell Transplant       Date:  2006       Impact factor: 4.064

7.  The spleen contributes to stroke-induced neurodegeneration.

Authors:  Craig T Ajmo; Dionne O L Vernon; Lisa Collier; Aaron A Hall; Svitlana Garbuzova-Davis; Alison Willing; Keith R Pennypacker
Journal:  J Neurosci Res       Date:  2008-08-01       Impact factor: 4.164

8.  A role for interferon-gamma in focal cerebral ischemia in mice.

Authors:  Kate Lykke Lambertsen; Rikke Gregersen; Michael Meldgaard; Bettina Hjelm Clausen; Eva Kildall Heibøl; Rune Ladeby; Jens Knudsen; Aase Frandsen; Trevor Owens; Bente Finsen
Journal:  J Neuropathol Exp Neurol       Date:  2004-09       Impact factor: 3.685

9.  Increased production of gelatinase B (matrix metalloproteinase-9) and interleukin-6 by activated rat microglia in culture.

Authors:  P E Gottschall; X Yu; B Bing
Journal:  J Neurosci Res       Date:  1995-10-15       Impact factor: 4.164

10.  Reversible middle cerebral artery occlusion without craniectomy in rats.

Authors:  E Z Longa; P R Weinstein; S Carlson; R Cummins
Journal:  Stroke       Date:  1989-01       Impact factor: 7.914

View more
  59 in total

1.  Acute splenic responses in patients with ischemic stroke and intracerebral hemorrhage.

Authors:  Farhaan S Vahidy; Kaushik N Parsha; Mohammad H Rahbar; MinJae Lee; Thanh-Tung Bui; Claude Nguyen; Andrew D Barreto; Arvind B Bambhroliya; Preeti Sahota; Bing Yang; Jaroslaw Aronowski; Sean I Savitz
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-02       Impact factor: 6.200

2.  Splenectomy Does Not Improve Long-Term Outcome After Stroke.

Authors:  Dannielle Zierath; Angela Shen; Astiana Stults; Theresa Olmstead; Kyra J Becker
Journal:  Stroke       Date:  2017-01-13       Impact factor: 7.914

3.  Neuroprotective Properties of a Macrolide Antibiotic in a Mouse Model of Middle Cerebral Artery Occlusion: Characterization of the Immunomodulatory Effects and Validation of the Efficacy of Intravenous Administration.

Authors:  Diana Amantea; Michelangelo Certo; Francesco Petrelli; Giacinto Bagetta
Journal:  Assay Drug Dev Technol       Date:  2016-07-08       Impact factor: 1.738

Review 4.  Regulatory B cells in experimental stroke.

Authors:  Hilary A Seifert; Arthur A Vandenbark; Halina Offner
Journal:  Immunology       Date:  2018-02-05       Impact factor: 7.397

5.  Peripheral TREM1 responses to brain and intestinal immunogens amplify stroke severity.

Authors:  Qingkun Liu; Emily M Johnson; Rachel K Lam; Qian Wang; Hong Bo Ye; Edward N Wilson; Paras S Minhas; Ling Liu; Michelle S Swarovski; Stephanie Tran; Jing Wang; Swapnil S Mehta; Xi Yang; Joshua D Rabinowitz; Samuel S Yang; Mehrdad Shamloo; Christoph Mueller; Michelle L James; Katrin I Andreasson
Journal:  Nat Immunol       Date:  2019-07-01       Impact factor: 25.606

6.  Targeting the peripheral inflammatory response to stroke: role of the spleen.

Authors:  Keith R Pennypacker
Journal:  Transl Stroke Res       Date:  2014-09-26       Impact factor: 6.829

7.  Chronic Alterations in Systemic Immune Function after Traumatic Brain Injury.

Authors:  Rodney M Ritzel; Sarah J Doran; James P Barrett; Rebecca J Henry; Elise L Ma; Alan I Faden; David J Loane
Journal:  J Neurotrauma       Date:  2018-05-03       Impact factor: 5.269

8.  Endogenous Protection from Ischemic Brain Injury by Preconditioned Monocytes.

Authors:  Lidia Garcia-Bonilla; David Brea; Corinne Benakis; Diane A Lane; Michelle Murphy; Jamie Moore; Gianfranco Racchumi; Xinran Jiang; Costantino Iadecola; Josef Anrather
Journal:  J Neurosci       Date:  2018-06-26       Impact factor: 6.167

Review 9.  Neuroimmune Response in Ischemic Preconditioning.

Authors:  Ashley McDonough; Jonathan R Weinstein
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

10.  Correction to: Neuroimmune Response in Ischemic Preconditioning.

Authors:  Ashley McDonough; Jonathan R Weinstein
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.